Impact of pre-therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV-specific T-cell therapy.

Walker, David G; Shakya, Reshma; Morrison, Beth; Neller, Michelle A; Matthews, Katherine K; Nicholls, John; Smith, Corey; Khanna, Rajiv

Walker, David G; Shakya, Reshma; Morrison, Beth; Neller, Michelle A; Matthews, Katherine K; Nicholls, John; Smith, Corey; Khanna, Rajiv.

Afiliación

Walker DG; Newro Foundation The Wesley Hospital Brisbane QLD Australia.
Shakya R; School of Medicine University of Queensland Brisbane QLD Australia.
Morrison B; QIMR Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory QIMR Berghofer Medical Research Institute Brisbane QLD Australia.
Neller MA; Newro Foundation The Wesley Hospital Brisbane QLD Australia.
Matthews KK; QIMR Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory QIMR Berghofer Medical Research Institute Brisbane QLD Australia.
Nicholls J; QIMR Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory QIMR Berghofer Medical Research Institute Brisbane QLD Australia.
Smith C; Department of Pathology Queen Mary Hospital The University of Hong Kong Hong Kong.
Khanna R; QIMR Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory QIMR Berghofer Medical Research Institute Brisbane QLD Australia.

Clin Transl Immunology ; 8(11): e01088, 2019.

Article en En | MEDLINE | ID: mdl-31929892

Palabras clave

adoptive immunotherapy; cytomegalovirus (CMV); glioblastoma multiforme; tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Transl Immunology Año: 2019 Tipo del documento: Article Pais de publicación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google